Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Bausch + Lomb Corp

BLCO ✗ NOT COMPLIANT ☆ Track — members

NYSE · Healthcare · Medical Equipment, Supplies & Distribution ·

USA Mid Cap Analyst: HOLD

Last Close

$18.04

▼ -0.55%

Market Cap $6.44B · Vol 83.58K

Key Metrics

P/E Ratio

N/A

FWD: 18.46

Market Cap

$6.44B

Mid Cap

Div Yield

N/A

EPS Growth

+58.20%

YoY

RSI (14)

74.53

Momentum

Beta

0.56

vs Market

52W High

$18.91

4.60% below

52W Low

$13.79

30.82% above

Volume

83.58K

Avg 109.88K

P/B

0.94

Price-to-book

ROE

2.82%

Return on equity

Free Float

12.60%

Public shares

Shariah Compliance8 STANDARDS

✗ Bausch + Lomb Corp (BLCO) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does BLCO pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+5.19%

+8.15%

+17.52%

-0.06%

YTD

+5.62%

+23.65%

+0.95%

N/A

Financials & Valuation

TTM · Annual

Total Revenue	$5.10B
Net Income	$-352,000,000.00
Revenue Growth (YoY)	+9.08%
Gross Margin	54.75%
Operating Margin	3.69%
Net Profit Margin	-6.90%
ROE	2.82%
ROA · ROIC	-2.31% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	18.46
PEG Ratio	N/A
P/S	1.18
P/B	0.94
P/FCF	N/A
EPS Growth	+58.20%
Outstanding Shares	357.17M

Technical Indicators

50-Day SMA	$16.82
200-Day SMA	$16.55
RSI (14)	74.53
Beta	0.56
52-Week High	$18.91
52-Week Low	$13.79

Volume Today	83.58K
Avg Daily Volume (30D)	109.88K
Relative Volume	0.76x
Volatility (10D)	14.94
Volatility (30D)	23.29
Free Float	12.60%

Analyst Consensus

HOLD

Current Price $18.04

Mean Target $18.64

52W Low$13.79 52W High$18.91

Current

Target

$13.79 $18.91

Current Analyst target

+3.31% upside potential · 13 analysts

Identifiers

ExchangeNYSE

FIGIBBG014KG1GY8

ISINCA0717051076

CountryCanada

Sub-IndustryMedical Equipment, Supplies & Distribution (NEC)

Earnings DateOct 29, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

ABT Abbott Laboratories -0.42% MDT Medtronic PLC +1.15% COR Cencora Inc -1.86% 7741.T Hoya Corp -1.31% BDX Becton Dickinson and Co -1.54%

Company Profile

Bausch + Lomb Corporation is an eye health company. It operates through three segments: Vision Care, Pharmaceuticals, and Surgical. Vision Care segment includes both a contact lens and a consumer eye care business that consists of contact lens care products, over-the-counter eye drops and eye vitamins. Pharmaceuticals segment consists of generic pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. Surgical segment consists of medical device equipment, consumables, instruments and technologies for the treatment of cataracts, corneal and vitreous and retinal eye conditions, which includes delivery systems, phacoemulsification equipment and other surgical instruments and devices for cataract surgery. Its brands consist of PreserVision, Biotrue, Artelac, Alaway, Mioclear, Ocuvite, ScoutPro, XIIDRA, Vyzulta, Lotemax, Prolensa, Minims, INFUSE, and many more.